
GO
HSI1 | 26,545.10 | +0.25 | 376.81B |
HSCEI1 | 9,472.35 | +15.83 | 129.31B |
Back Zoom + Zoom - Block Traded | |
2025-09-19 10:43:23 According to CLSA's research report, prescription drugs were driving accelerated growth in China's online pharmacy revenue for 2025. JD HEALTH (06618.HK) guided YoY increases of around 20%/ 15% in the 2025 revenue/ adjusted net profit, while ALI HEALTH (00241.HK) guided YoY increases of 10-15%/ 20-30% in the revenue/ adjusted net profit for the fiscal year ended March 2026. While most retail categories have already achieved high online penetration rates, CLSA believes that pharmaceuticals have the greatest growth potential online. ~ AAStocks Financial News Web Site: www.aastocks.com |